SuDDICU Trial Presentation
Critical Care Reviews Podcast
The Effects of Standard Care on Infection Rate in the SDD Group
The drug manufacturing was a very big part of the trial. We had no money to do that. So we are running a little short on time, and I think this trial deserves actually some clinical interpretation as well beyond just the design. And whether that becomes now a mass-produced agent now in the future is to be seen on this trial. But you have to take those hard, pragmatic, logistical decisions to deliver a study because we couldn't afford for the trial to fail because we were not a drug.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
